Literature DB >> 19931642

Pharmacological approaches to the treatment of tinnitus.

Ana B Elgoyhen1, Berthold Langguth.   

Abstract

Tinnitus is the conscious perception of a phantom sound in the absence of an external source. For 1 in 100 of the general population, the condition severely affects quality of life. In spite of the fact that the market for a drug indicated for tinnitus relief is huge, there are still no FDA-approved drugs, and the quest for a tinnitus-targeted compound faces important challenges. A wide variety of drugs have been used off-label to treat tinnitus sufferers, with limited but significant effects in subsets of patients. If the compounds being developed at present by the pharmaceutical industry finally reach the market, they will establish a turning point in the treatment of this pathology. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19931642     DOI: 10.1016/j.drudis.2009.11.003

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  23 in total

1.  Phantom percepts: tinnitus and pain as persisting aversive memory networks.

Authors:  Dirk De Ridder; Ana Belen Elgoyhen; Ranulfo Romo; Berthold Langguth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

2.  Tinnitus Correlates with Downregulation of Cortical Glutamate Decarboxylase 65 Expression But Not Auditory Cortical Map Reorganization.

Authors:  Asako Miyakawa; Weihua Wang; Sung-Jin Cho; Delia Li; Sungchil Yang; Shaowen Bao
Journal:  J Neurosci       Date:  2019-11-08       Impact factor: 6.167

Review 3.  The efferent medial olivocochlear-hair cell synapse.

Authors:  Ana Belén Elgoyhen; Eleonora Katz
Journal:  J Physiol Paris       Date:  2011-07-06

4.  Neuroanatomical correlates of tinnitus revealed by cortical thickness analysis and diffusion tensor imaging.

Authors:  Faten M Aldhafeeri; Ian Mackenzie; Tony Kay; Jamaan Alghamdi; Vanessa Sluming
Journal:  Neuroradiology       Date:  2012-05-22       Impact factor: 2.804

Review 5.  Antidepressants for patients with tinnitus.

Authors:  Paolo Baldo; Carolyn Doree; Paola Molin; Don McFerran; Sara Cecco
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

6.  Treatment of chronic tinnitus with repeated sessions of prefrontal transcranial direct current stimulation: outcomes from an open-label pilot study.

Authors:  Elmar Frank; Martin Schecklmann; Michael Landgrebe; Julia Burger; Peter Kreuzer; Timm B Poeppl; Tobias Kleinjung; Göran Hajak; Berthold Langguth
Journal:  J Neurol       Date:  2011-08-02       Impact factor: 4.849

7.  Methodological aspects of clinical trials in tinnitus: a proposal for an international standard.

Authors:  Michael Landgrebe; Andréia Azevedo; David Baguley; Carol Bauer; Anthony Cacace; Claudia Coelho; John Dornhoffer; Ricardo Figueiredo; Herta Flor; Goeran Hajak; Paul van de Heyning; Wolfgang Hiller; Eman Khedr; Tobias Kleinjung; Michael Koller; Jose Miguel Lainez; Alain Londero; William H Martin; Mark Mennemeier; Jay Piccirillo; Dirk De Ridder; Rainer Rupprecht; Grant Searchfield; Sven Vanneste; Florian Zeman; Berthold Langguth
Journal:  J Psychosom Res       Date:  2012-06-22       Impact factor: 3.006

Review 8.  The α9α10 nicotinic acetylcholine receptor: a compelling drug target for hearing loss?

Authors:  Ana Belén Elgoyhen
Journal:  Expert Opin Ther Targets       Date:  2022-03-07       Impact factor: 6.902

Review 9.  Chronic tinnitus: an interdisciplinary challenge.

Authors:  Peter M Kreuzer; Veronika Vielsmeier; Berthold Langguth
Journal:  Dtsch Arztebl Int       Date:  2013-04-19       Impact factor: 5.594

10.  The evaluation of ozone and betahistine in the treatment of tinnitus.

Authors:  Onur Sönmez; Ismail Külahlı; Alperen Vural; Mehmet Ilhan Sahin; Mesut Aydın
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-26       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.